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Generalizedaggressiveperiodontitisresultsinrapiddestructionoftheperiodontiumandcanleadtoearlytoothlossintheaﬀected
individuals if not diagnosed early and treated appropriately. The diagnostic features of the disease are characteristic, but the
clinical presentation and patterns of destructions may vary between patients. Successful management of the disease is challenging
especially if diagnosed at advanced stages of the disease, but not impossible with the current therapeutic choices for the disease.
A vast array of treatment modalities is available which can be employed in the treatment of generalized aggressive periodontitis
with varying success rates, but a deﬁnite guideline for the management is yet to be formulated. However, with the exponential
rate of developments in periodontal research, regenerative therapy, tissue engineering, and genetic technologies, the future seems
promising in regard to options at managing the disease. This paper attempts to describe the clinical and radiographic diagnostic
features and the current treatment options along with a suggested protocol for comprehensive management of generalized
aggressive periodontitis patients with case reports and a brief review.
1.Introduction
Aggressive periodontitis, as the name implies is a type of
periodontitis where there is rapid destruction of periodontal
ligament and alveolar bone which occurs in otherwise
systemically healthy individuals generally of a younger age
group but patients may be older [1, 2]. Although its
prevalence has been reported to be much less than that of
chronic periodontitis, it can result in early tooth loss in the
aﬀected individuals if not diagnosed in the early stages and
treated appropriately [3]. The disease is generally found to
have a racial and sex predilection, with blacks and male
teenagers having higher risk for the disease compared to
whites and females, although reports vary between diﬀerent
ethnic groups and populations, with some populations
showing prevalence as high as 28.8% [4, 5].
Aggressive periodontitis, ﬁrst described in 1923 as “dif-
fuse atrophy of the alveolar bone” [6], has undergone a series
of terminology changes over the years to be ﬁnally named as
“aggressive periodontitis” in 1999 [1, 7]. The disease which
includes both localized and generalized forms was previously
known as “early onset periodontitis” which included the
three categories of periodontitis—prepubertal, juvenile, and
rapidly progressing periodontitis [8, 9]. It is interesting that
the ﬁrst ever reported detailed description of a recognized
disease in early hominid evolution is a case of prepubertal
periodontitis in an 2.5–3-million-year-old fossil remains
of a juvenile Australopithecus africanus specimen which
showed the typical pattern of alveolar bone destruction with
migration of the aﬀected deciduous molars [10, 11].
Generalizedaggressiveperiodontitis(GAgP)ischaracter-
ized by “generalized interproximal attachment loss aﬀecting
at least 3 permanent teeth other than ﬁrst molars and
incisors” [12]. It is a multifactorial disease where interplay
of microbiologic, genetic, immunologic, and environmen-
tal/behavioral risk factors decides the onset, course, and
severity. Pathogenic bacteria in the dental plaque especially
Aggregatibacter actinomycetemcomitans and Porphyromonas
gingivalis [13, 14] have an indispensable role which elicits
an aggravated host response which in turn is determined by2 Case Reports in Medicine
the genetic and immunologic proﬁle of the patient modiﬁed
by environmental risk factors like smoking.
This paper attempts to describe the diagnostic fea-
tures along with the periodontal management options of
generalized aggressive periodontitis with the help of case
r e p o r t sw i t hd i ﬀerent clinical presentation and patterns of
involvement and managed with diﬀerent treatment modal-
ities available. Finally an attempt to summarize the available
protocol for a comprehensive management of GAgP is done
which can serve as a guideline till more deﬁnite clear-cut
guidelines are established for the disease in the future.
2.ClinicalFeatures
The most common reported complaints are a recently
noticed ﬂaring and progressing spacing of anterior teeth and
bleeding from gums comparatively in a young patient but
patients can be older as well (Figures 1(a)–1(c)).
Patients may complain of halitosis and pus discharge
fromgums.Mobilityoftheaﬀectedteethwillbeseentowards
the later stages of the infection. Patients will be otherwise
systemically healthy. Severe pain is rarely experienced by
the patients except in situations where a periodontal abscess
develops or a periodontal-endodontic infection occurs via
accessory canals or tooth apex. Some patients may complain
of a dull nagging type of pain from gums. Gingival recession
may be seen and patients may complain of food impaction
due to loss of contact points between teeth.
GAgP patients who smoke and/or maintain a poor oral
hygiene demonstrate more severe destruction of periodon-
tium compared to those who do not smoke or maintain a
satisfactory oral hygiene (Figures 2(a)–2(e)).
The disease progresses in alternating periods of activity
and quiescence [15]. This leads to two types of presentation
at the time of examination. In the periods of quiescence,
patients are free of symptoms and the gingiva appears pink
and healthy even though probing reveals deep periodontal
pockets. Lack of visible signs of clinical inﬂammation
despite the presence of deep periodontal pockets and severe
attachment loss in an otherwise healthy young individual
is the classic sign of aggressive periodontitis presenting at
this stage (Figures 1(a)–1(c)). Probing should be done with
calibrated periodontal probes at six sites around each tooth.
The periods of inactivity may remain for weeks to
months or even years and will be followed by periods of
active disease. During this period, there will be active
bone destruction and attachment loss. When the patient
presents in this stage, the gingiva will show all signs of
mild to severe inﬂammation. Gingiva may be tender, ﬁery
red, edematous, soft, and boggy. Bleeding on probing or
even spontaneous bleeding and purulent exudation may
be evident. Inﬂammatory gingival enlargement may also
be noticed. The majority of the patients refer to dental
consultation at this stage of the disease (Figures 3(a)–3(c)).
This stage may undergo spontaneous remission after
a varying period of destruction and the inﬂammatory
symptoms subside to reappear after a period of quiescence.
Advanced stages of the untreated disease with severe peri-
odontal destruction may show extrusion of teeth, mobility
and pathologic migration, furcation involvement, general-
ized gingival recession, and loss of several teeth due to
spontaneous exfoliation. Some patients may show systemic
manifestations such as weight loss, mental depression and
general malaise [16].
3.RadiographicFeatures
Localized aggressive periodontitis typically presents “arc-
shaped” mirror image radiolucency in the ﬁrst molars
starting from the distal aspect of second premolars to
the mesial aspect of the second molar. In generalized
aggressive periodontitis, radiographs may show generalized
bone destruction ranging from mild crestal bone resorption
to severe extensive alveolar bone destruction depending on
the severity of the disease. The defects may be a combination
of vertical and horizontal defects (Figures 4(a) and 4(b)).
4.Diagnosis
Early diagnosis is of utmost importance for the prevention
of extensive attachment loss and bone loss experienced in
aggressive periodontitis. Diagnosis is made according to the
criteria set by the American Academy of periodontology,
1999 classiﬁcation of periodontal diseases and conditions
[1], using history, clinical features, and radiographic features
aided by microbial examination if needed. Family history
may reveal a history of early tooth loss in the parents or
immediate blood relatives of the patient [17]. The amount
of microbial deposits will be inconsistent with the amount
of destruction when compared to chronic periodontitis and
plaque will be minimal. Comparison of serial radiographs
helps in assessing the rapid rate of bone destruction and can
aid in the diagnosis of the disease.
5. DifferentialDiagnosis
Aggressive periodontitis can be diﬀerentiated from chronic
periodontitis by the age of onset, rapid rate of disease
progression, the nature and composition of the associated
subgingivalmicroﬂora,alterationsinhostimmuneresponse,
and a familial aggregation of the diseased individuals [18].
Systemic diseases like hematologic disorders and some
genetic disorders also show periodontitis as a manifestation
mimicking generalized aggressive periodontitis which can
be ruled out by assessing the systemic status, hematologic
data analysis, and immunologic proﬁling of the patient.
In addition, there are rare reports of certain conditions
like intraosseous sarcoidosis [19], eosinophilic granuloma
[20, 21] and alveolar bone actinomycosis [22], presenting
with extensive alveolar bone destruction like in aggressive
periodontitis which can be diﬀerentiated by biopsy of the
suspected lesions.Case Reports in Medicine 3
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Figure 2: (a)–(d) Clinical and radiographic appearance of GAgP in a 25-year-old smoker with poor oral hygiene. (e) A 19-year-old smoker
with GAgP demonstrating severe periodontal destruction.
(a) (b) (c)
Figure 3: (a)–(c) Features of severe gingival inﬂammation presented at the stage of active disease.4 Case Reports in Medicine
(a) (b)
Figure 4: (a) Arc-shaped radiolucency at the 1st molar region in localized aggressive periodontitis. (b) Generalized distribution of bone loss
seen in GAgP with vertical defects.
6.CaseReports
6.1. Case Report 1. A 32-year-old female patient presented
with the complaint of a recently noticed spacing between the
upper front teeth. (Figures 5(a)–5(d)).
The patient noticed the spacing about 1 year before, after
whichshenoticedittobegraduallyincreasingandassociated
with intermittent episodes of pus discharge which subsided
on taking antibiotics as per advice at a local hospital. There
werenoassociatedcomplaintsotherthanacosmeticconcern
fromthepatient.Therewasnohistoryofanypreviousdental
treatment. Family history of similar complaints or early
tooth loss could not be elicited. The patient was systemically
healthy with no relevant medical history.
There were no abnormalities detected in extra oral
examination except for a slightly tender and palpable left
submandibular lymph node. Full complement of teeth was
present. The oral hygiene status of the patient was good
as revealed by the oral hygiene index. There was minimal
amount of calculus and plaque. There was grade I mobility
of 22, 31, 32, 21 and 22. Proximal contacts were lost between
the teeth 14 and 13, 13 and 12, 21 and 22 and 22 and 23,
22 and 24 and between lower anterior teeth. There was labial
migration and ﬂaring of upper and lower anterior teeth with
an evident distolabial migration of 22.
Gingival examination revealed normal color except for
the labial aspect of 22 where it was slightly reddish. The
margins were of knife-edge contour except for the labial
aspectof22and42whereitwasbluntlyrounded.Thegingiva
was ﬁrm and resilient except in the region on 22 where it
was soft in consistency. There was no loss of stippling in
the anterior regions. The position of the gingival margin
was apical to the CEJ in the labial aspect of 22. There was
generalized bleeding on probing, and exudation was present
on the labial aspect of 22. All together there were minimal
signs of inﬂammation other than bleeding on probing.
A full-mouth periodontal charting revealed generalized
periodontal pockets and clinical attachment loss (Figure 6).
Pockets were especially deeper in the molar and incisor
regions with slightly lesser involvement in the premolar
region.Theclinicalattachmentlossrangedfromamaximum
of 10mm in the midpalatal aspect of 16 to a minimum of
2mm in the premolar regions.
An OPG and full-mouth IOPA X-ray were performed
which revealed the generalized distribution of alveolar bone
loss which was a combination of both horizontal and vertical
boneloss(Figure 7).Routinebloodexaminationresultswere
within normal limits.
Based on the history, examination ﬁndings, and the
radiographic ﬁndings, a diagnosis of generalized aggressive
periodontitiswasmadeaccordingtothecriteriabyAAP1999
classiﬁcation.
6.2. Management. A thorough supragingival scaling was
performed following which the patient was motivated for
betterplaquecontrol.Asulcusbrushingtechnique(modiﬁed
Bass technique) [23] was demonstrated, and the patient was
educated on the use of interdental cleansing aids including
dental ﬂoss and interdental brushes. Chlorhexidine mouth
wash was prescribed to further aid in plaque control. Sys-
temicantibiotics(AmoxycillinandMetronidazole,250mgof
each thrice daily) were prescribed for 8 days, and the patient
was recalled after 2 weeks for evaluation of the response to
treatment [24].
A subgingival scaling was performed after which the pa-
tient was advised to continue the chlorhexidine mouthwash-
es. A reevaluation 2 weeks after subgingival scaling showed
a reduction in probing depths and absence of bleeding on
probing.
A quadrant-wise full-mouth ﬂap surgery was performed
including bone grafting in relation to the molar regions
where predominantly vertical or intrabony defects were
detected. A modiﬁed Widman ﬂap surgery [25]i nc o n -
junction with bone replacement graft was performed in the
molarregions(Figures8(a)–8(e))whereasasulcularincision
ﬂap (Kirkland ﬂap) was performed in the maxillary and
mandibular anterior region to minimize the recession after
healing for esthetic purposes.
A preprocedural rinse with antimicrobial agent was done
to minimize the bacterial count in the mouth. After ade-
quately anesthetizing the surgical site with inﬁltration anes-
thesia and nerve blocks, the ﬁrst incision (internal bevelCase Reports in Medicine 5
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Figure 5: (a)–(d) Deep pockets were present even though signs of gingival inﬂammation other than bleeding on probing were absent.
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Figure 6: Periodontal charting showing generalized deep pockets
and clinical attachment loss.
Figure 7: Orthopantomogram of the patient demonstrating gener-
alized distribution of bone loss.
incision) 0.5mm from the gingival margin directing to the
crest of the alveolar bone was made. The ﬂap was reﬂected
following which sulcular incision and interdental incision
were made to remove the wedge of tissue. Curettage for
granulation tissue removal was done following which a
through subgingival debridement and root planning was
performed. The defect was irrigated with normal saline, and
a root conditioning with tetracycline was performed. The
graft was a xenograft (Bovine graft—Ossopan), which was
mixed with the blood from the surgical site and placed into
the defect after presuturing the site with silk sutures. Care
was taken to ﬁll the graft to a realistic level and not to
overpack the defect. Suturing was done after adapting the
buccal and lingual ﬂaps well. A periodontal pack was placed,
and antibiotics and analgesics were prescribed for the patient
for 5 days. A ﬂuoride-containing mouthwash was prescribed
postsurgically to the patient.
Healing was uneventful, and a postoperative evaluation 3
weeks after surgery showed absence of bleeding on probing
and probing depths within normal limits (Figure 8(f)). The
patientwasputonregularrecallappointmentsforevaluation
of the gingival and periodontal status and maintenance
therapy. A postoperative radiograph 6 months later showed
a signiﬁcant bone ﬁll in the molar regions where grafting
was done with an increase in bone density of the alveolar
crest with corticated bone formations in the crest at the
other areas (Figure 8(g)). The oral hygiene maintenance
and compliance of the patient was excellent, and there
were no signs of recurrence of the disease throughout the
maintenance period. Since the patient was concerned about
the esthetic appearance of the anterior teeth, she was advised
to undergo adult orthodontic therapy after 1 year of surgery
under regular periodontal monitoring and was referred to an
orthodontic specialist for the same.
6.3. Case Report 2. A 26-year-old male patient presented
with the chief complaint of generalized pus discharge from
gums which he had been experiencing intermittently for the
past 2 years (Figures 9(a) and 9(b)). Pus discharge was asso-
ciated with bad breath and usually subsided spontaneously
after a few weeks. There was no associated complaint other
than a generalized mild hypersensitivity to cold and sweet
food. He had a history of extraction of lower left posterior
tooth due to caries exposure and extraction of lower front
tooth due to mobility about 1 year before. There was no
history of any other dental treatment.
The patient was systemically healthy, and medical history
did not reveal any relevant ﬁndings. Family history revealed
that the patient’s mother had similar complaints of mobility,
pus discharge, and spontaneous exfoliation of some teeth
following which she consulted a dentist and underwent total
extractionbytheageof40.Thepatientwasanonsmoker,and
there was no history of use of any other forms of tobacco.
Extraoral examination revealed bilateral submandibular
lymph node enlargement, which was ﬁrm, mobile, and non-
tender.
All teeth were present except for 46, 26, and 41. Tooth
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Figure 8: (a)–(e) Modiﬁed Widman ﬂap in conjunction with bone grafting performed. (f) Postoperative evaluation showing probing depth
within normal limits. (g) 6-Month postoperative intraoral periapical radiographs.
(a) (b)
Figure 9: (a) and (b) Clinical presentation with deep pockets, recession, and pathologic migration of teeth.Case Reports in Medicine 7
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Figure 10: Pretreatment periodontal charting shows deep pockets
with generalized clinical attachment loss.
present. The oral hygiene status of the patient was fair with
moderate deposits of calculus and plaque.
Intraoral examination revealed a normal color of gingiva
except in the labial aspect of 31, 32, and 33 where the
marginal gingiva was slightly reddish. Gingival margins were
rounded, and exudation was present in relation to labial
aspects of mandibular anterior teeth and maxillary central
incisors. There was generalized bleeding on probing and
recession in relation to most of the teeth, especially more in
maxillary central incisors and mandibular anterior teeth.
There was grade I mobility of 15 and 22 and grade II
mobility of 11, 12, 21, 31, 32, 33 and 42. Proximal contacts
were lost between maxillary and mandibular anterior teeth
with pathologic migration of 11, 21, 31, 32, and 42 and
extrusion of 31. Grade II furcation involvement was present
with molars and maxillary ﬁrst premolars. A full mouth
periodontal examination revealed generalized deep peri-
odontal pockets and severe generalized clinical attachment
loss (Figure 10).
Severe periodontal destruction was evident with more
than 10mm of clinical attachment loss at multiple sites
especially in the incisor and canine regions.
OPGandIOPAX-raysrevealedageneralizeddistribution
of periodontal bone loss especially severe in the incisor and
canine regions with the molars and premolars aﬀected to a
lesser degree (Figure 11). There was predominantly vertical
bone loss in the canine and incisor regions. Routine blood
investigations were within normal limits.
A diagnosis of generalized aggressive periodontitis was
made according to the established criteria (American Acad-
emy of Periodontology, 1999).
6.4. Management. Supragingival scaling was performed, and
the patient was educated in oral hygiene maintenance. The
patient was advised to follow a modiﬁed Stillman tech-
nique of brushing since the patient had root exposure and
Figure 11:Orthopantomogramshowinggeneralizedbonelosswith
advanced vertical defect in 13 and 33 regions.
hypersensitivity and also advised to use interdental brushes
and dental ﬂoss for optimal plaque control. The patient
was prescribed topical antimicrobial agents (metronidazole
gel) along with chlorhexidine mouthwash for 2 weeks. A
combination systemic antibiotic therapy of amoxicillin and
metronidazole [24] was initiated, and a desensitizing agent
was prescribed. A recall visit after 2 weeks showed reduction
in inﬂammation and percentage of sites showing bleeding
on probing. Exudation was persistent in relation to 11 and
33 regions. A subgingival scaling and root planing was
performed following which a povidone iodine 5% irrigation
wasperformed.Anonsustainedprofessionallydeliveredlocal
drug delivery with metronidazole gel was injected subgin-
givally at sites 33 and 11, following which a periodontal
dressing was given at the site. The procedure was performed
every 3 days for the next 2 weeks. Evaluation after 3 weeks
showedcompleteabsenceofbleedingonprobing,exudation,
and signiﬁcant reduction in probing pocket depth. The
patient was put on maintenance therapy during which
he continued with the topical antimicrobial agents and
desensitizing agents and was evaluated for surgical therapy.
A full-mouth ﬂap surgery with bone grafts (synthetic
hydroxyapatite (HAP)), where indicated, was performed
sextantwise at intervals of two weeks. In addition, the defect
at site 33 was treated with guided tissue regeneration (GTR)
with bioresorbable collagen membrane in conjunction with
synthetic bone graft (HAP) (Figures 12(a)–12(f)).
Postoperative clinical evaluation showed excellent gingi-
val condition with reduction in probing depths to normal
levels (Figures 13(a) and 13(b)). Radiographs showed bone
ﬁll in the region where bone grafts alone or in conjunction
withGTRwereused(Figures13(c)and13(d)).Regularrecall
appointments were given for maintenance therapy during
which the treatment results were well maintained. However,
there was a slight increase in recession due to shrinkage
of gingiva on healing and hypersensitivity after the surgery
which gradually subsided on regular use of desensitizing
agents and ﬂuoride mouthwashes.
7. Discussion
The key to successful treatment is early diagnosis. Early
diagnosis helps in prevention of progression of the disease
thus avoiding the possibility of advanced tissue destruction
and alveolar bone loss. The earlier the diagnosis is the better8 Case Reports in Medicine
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Figure 12: (a)–(c) Flap surgery in conjunction with bone grafting (HAP) and papilla preservation ﬂap between 11 and 21. (d)–(f) Deep
circumferential defect treated with bone grafting in conjunction with guided tissue regeneration.
(a) (b) (c) (d)
Figure 13: (a) and (b) Postoperative photographs showing probing depths within normal limits with excellent gingival condition; however,
there was slight increase in recession after healing. (c) and (d) Comparison of preoperative and 1 year postoperative radiographs shows good
bone ﬁll at the defect in relation to 33.
the prognosis of the dentition will be. Furthermore since it
has a tendency for familial aggregation, it is important to
do a periodontal examination of siblings and other close
blood relatives of the patient which helps in early diagnosis
of the disease in the family members. Management of GAgP
patients essentially consists of a nonsurgical phase, surgical
therapyaninterdisciplinarytherapyandalifelongsupportive
periodontal therapy.
7.1. Nonsurgical/Etiotropic Phase of Therapy. Nonsurgical
therapy remains the ﬁrst line of antimicrobial therapy in
GAgP. Early stages of the disease with mild to moderate
periodontal and bone destruction may be managed entirely
by nonsurgical therapy with systemic antibiotics as an ad-
juvant to mechanical therapy.
Therapy should start with attempts at controlling or
eliminating the etiologic agents and modiﬁable risk factors
for the disease. The disease has a strong genetic predispo-
sition. The host response of the patient or the susceptible
individual to pathogenic bacteria in the dental plaque plays a
vital role in the pathogenesis and expression of the disease,
and this host response is genetically determined and is
an unmodiﬁable risk factor is at present by the current
treatment measures [26]. However, since the expression of
the disease in susceptible individuals is also inﬂuenced by
microbial and environmental risk factors, the disease can be
successfully kept under control by controlling the microbial
and environmental factors. This underlies the importance
of optimal plaque control both by personally employed
methods used by the patient himself and professionally
employed plaque control measures by the dental team to the
patient. Even a minimal amount of plaque is enough to elicit
untoward host response in those patients susceptible to the
disease, and a reduced resistance to the invasion of subgin-
gival plaque can be compensated for by a correspondingly
strong emphasis on total plaque control [27].
Mechanical plaque control can be successfully achieved
by educating and motivating the patient if needed withCase Reports in Medicine 9
the aid of disclosing solutions regarding the need for opti-
mal plaque control, demonstration of brushing techniques
(modiﬁed Bass technique for patients without gingival reces-
sionandmodiﬁedStillmantechniqueinpatientswithhyper-
sensitivity and generalized recession), and use of interdental
cleansing aids like dental ﬂoss and interdental brushes where
indicated. This behavioral modiﬁcation from the patient
needs a positive reinforcement and encouragement from the
dental team. Regular recall appointments to monitor the
eﬃcacy of the patient’s plaque control measures are essential.
Chemical plaque control agents like chlorhexidine 0.12%
or 0.2% mouthwashes, and 1% povidone iodine can be ad-
vised for further plaque control as an adjunct to the patient’s
mechanical plaque control measures [28]. Amine ﬂuoride
and stannous ﬂuoride mouth rinses and tooth pastes as
an adjunct to mechanical oral hygiene procedures in GAgP
patients were found to be eﬀective in controlling supragingi-
valplaqueaccumulationsinaggressiveperiodontitis[29,30].
Additionally use of ﬂuoride mouthwashes is advised to help
in remineralization of the exposed root surfaces, and for
patients complaining of hypersensitivity, use of desensitizing
toothpastes and mouthwashes is mandatory.
Smoking has been well documented as a signiﬁcant
risk factor for aggressive periodontitis with GAgP patients
who smoke having more aﬀected teeth and more loss of
clinical attachment than nonsmoking patients with GAgP
[31]. Furthermore the response to periodontal therapy,
both nonsurgical and surgical, regenerative therapy, and
implant therapy is less than in nonsmokers, but former
smokers respond similar to nonsmokers. This underlies the
therapeutic eﬀect of smoking cessation and cessation of
other forms of tobacco, and patients should be advised of
the beneﬁts of smoking cessation and the potential risks of
smoking in worsening their periodontal condition, and if
needed expert counseling for cessation of the habit should
be sought [32–36].
7.1.1. Mechanical Antimicrobial Therapy. Scaling and root
planing (SRP) which eliminates the microbial bacterial load
from the periodontal pockets and removes the local etiologic
factors is performed either as a quadrant-wise SRP at 2-
week interval or as a full mouth scaling and root planning
completed on the same day. However, both modalities have
been found to be eﬃcacious with signiﬁcant improvement
in clinical parameters, and the clinician should select the
treatment modality based on the practical considerations
related to the patient preference and clinical workload [37].
Another approach to mechanical antimicrobial therapy
is a one-stage full mouth disinfection therapy devised by
Quirynen et al., which was found to result in an improved
clinical outcome and microbial improvement in early onset
periodontitis compared to quadrant-wise SRP [38, 39]. Full-
mouth disinfection therapy includes full-mouth debride-
ment(scalingandrootplanning,brushingofthetonguewith
1% chlorhexidine for 1 minute, rinsing of the mouth with
a 0.2% chlorhexidine solution for 2 minutes, and irrigation
of periodontal pockets with 1% chlorhexidine solution),
completed in 2 appointments within a 24-hour period [40].
7.1.2. Photodynamic Therapy and Laser Irradiation. These
have been tried as adjuncts to mechanical therapy to inhibit
the pathogenic bacteria in periodontal pockets [41–44].
Photodynamic therapy (PDT) is a noninvasive photo-
chemical approach for infection control which combines the
application of a nontoxic chemical agent or photosensitizer
withlow-levellightenergyandhasshownclinicalevidenceof
eﬃcienteradicationofperiodontalbacteriafromsubgingival
sites [41]. This novel therapeutic approach of antimicrobial
therapy seems promising and is getting attention recently
either as a monotherapy or as an adjunct to SRP in the non-
surgical treatment of aggressive periodontitis. Both PDT and
SRP have been shown to have similar clinical results in the
nonsurgical treatment of aggressive periodontitis [42, 43].
Laser irradiation of subgingival sites to eradicate peri-
odontopathic microorganisms is also being considered in
thenonsurgicaltherapyofperiodontitis patients. Diodelaser
treatment has shown a superior clinical and microbiological
eﬀect when used along with SRP, compared to SRP alone or
laser therapy alone in aggressive periodontitis patients [44].
A regular recall visit preferably at one-week intervals
should be performed especially at the initial stages of the
treatment to monitor the eﬃciency of the patient’s plaque
control measures and to assess the response of the patient
towards nonsurgical therapy.
7.1.3. Chemical Antimicrobial Therapy in
the Management of GAgP
Role of Systemic Antibiotic Therapy in GAgP. Systemic anti-
biotics are indicated in aggressive periodontitis since the
pathogenic bacteria like Aggregatibacter actinomycetem-
comitans and Porphyromonas gingivalis have been found to
be tissue invasive and mechanical therapy is insuﬃcient to
eliminate the bacteria from these sites [58, 59]. Systemically
administered antibiotics with or without scaling and root
planning and/or surgery provided greater clinical improve-
ment in attachment level change compared to similar per-
iodontal therapy without antibiotics [45]. Earlier tetracy-
clines were used extensively for this purpose since systemic
tetracycline was found to be a useful adjunct to mechanical
periodontal therapy in patients with aggressive periodontitis
[46–48], but the concern for tetracycline resistance has
shifted the focus to the use of other antibiotics both as
combination therapy or serial antibiotic therapy [49].
The preferred combination antibiotic therapy at present
for treatment of GAgP is 250mg of amoxicillin thrice daily
along with metronidazole 250mg twice daily for 8 days
[24,49].Itisoneofthemostevaluateddrugcombinationsin
GAgP, and there is ample evidence now to show that Amox-
ycillin-Metronidazole combination as an adjunctive treat-
ment in GAgP at initial therapy signiﬁcantly improves the
results and hence should be preferred over other antibiotic
regimens as the ﬁrst-line treatment (Table 1)[ 50–55].
The usefulness of microbial testing may be limited
because of the variability of test reports between diﬀerent
labs and the mixed ﬂora, and hence an empiric use of anti-
biotics like the above-mentioned combination may be more10 Case Reports in Medicine
Table 1: The list of antibiotic regimens with evidence of superior clinical outcome when used as an adjuvant to SRP in GAgP [24, 45–57].
Mode of therapy Antibiotics used Usual recommended dosage
Combination therapy Metronidazole + Amoxicillin 250mg of each thrice daily for 8 days
Metronidazole + Ciproﬂoxacin 500mg of each twice daily for 8 days
Single-Agent therapy
Doxycycline or Minocycline 100–200mg once daily for 21 days
Metronidazole 500mg thrice daily for 8 days
Tetracycline 250mg 4 times daily for 1 week
Azithromycin 500mg once daily for 3 days
Clindamycin 300mg thrice daily for 10 days
clinically sound and cost-eﬀective than bacterial identiﬁca-
tion and antibiotic-sensitivity testing in the treatment of
aggressive periodontitis [49].
Single-agent therapy with Doxycycline [53, 55], azithro-
mycin [56], metronidazole [53, 57], and clindamycin [57]i s
eﬀective when used adjunctively to nonsurgical procedure of
SRP in AgP patients. The criteria for selection of antibiotics
are not clear in AgP; the choice depends on the case, disease-
related factors and patient-related factors like compliance,
allergies, and potential side eﬀects.
7.1.4. Local Drug Delivery of Antimicrobial Agents. Topical
application of antimicrobial agents and local drug delivery is
also a treatment option especially if there are localized areas
of exudation and deep pockets not responding adequately
to mechanical and systemic antibiotic therapy. Local drug
delivery delivers the drugs at high concentrations at the site
of infection when compared to systemic antibiotic therapy.
Furthermore, this is an option in patients where there is
intolerance to systemic administration of the antibiotic.
Several local anti-infective agents combined with SRP
appear to provide additional beneﬁts in PD reduction and
CAL gain compared to SRP alone. Over the past 20 years,
locallydelivered,anti-infectivepharmacologicalagents,most
recently employing sustained-release vehicles, have been
introduced to achieve this goal [60].
Though there is more evidence on its application in
chronic periodontitis, till future researches are available;
the same agents can be employed in aggressive periodon-
titis patients as well empirically. Adjunctive use of LDD
agents like controlled release biodegradable chlorhexidine
gluconate chip [61, 62], tetracycline ﬁbers [63, 64], and
minocycline-Hcl gel [65] has been tried in aggressive peri-
odontitis with superior clinical outcomes. The decision to
use local anti-infective adjunctive therapy remains a matter
of individual clinical judgment, the phase of treatment, and
the patient’s status and preferences.
An evaluation of the response to nonsurgical treatment
is done 2-3 weeks after treatment during which the gingival
and periodontal status of the patient will be reevaluated and
comparedwiththepretreatmentvaluestoassesstheresponse
to therapy and to assess the areas which need surgical
therapy. Sites with persisting pockets >5mm depth, vertical
bone defects which need regenerative therapy, diﬃcult to
instrument areas like furcation involvement, and areas which
needrecontouringorresectiveosteoplastyareindicationsfor
surgery.
7.2. Surgical Therapy. It essentially consists of open ﬂap
debridement either alone or as a combination with resective
orregenerativeprocedures.Themainaimofaﬂapprocedure
is to get access and visibility to root and furcation areas so
that a thorough instrumentation and debridement can be
performed. Flap techniques like modiﬁed Widman ﬂap [25],
modiﬁed ﬂap operation/Kirkland ﬂap (sulcular incision
ﬂap) [66] achieve this aim without eliminating the pockets.
A resective ﬂap procedure like undisplaced ﬂap [67]w i l l
eliminate the pockets as well but compromise the esthetics
and function of the dentition by root exposure and resultant
hypersensitivity and hence is not preferred usually when
compared to modiﬁed Widman ﬂap or sulcular incision ﬂap.
Laser-assisted surgery (Nd: YAG laser) is suggested as a
valid alternative to conventional scalpel surgical therapy, in
individuals at increased surgical risk like in coagulation and
platelet function disorders [68].
7.2.1. Regenerative Surgical Therapy. Regeneration of the
periodontal supporting structures lost due to periodontal
disease so that the form and function of the periodontium is
reestablished has been an elusive or diﬃcult-to-achieve goal
for periodontal therapists.
Various modalities are being employed for periodontal
regeneration which includes use of bone replacement grafts,
barrier membranes or guided tissue regeneration (GTR),
biologic modiﬁers like growth and diﬀerentiation factors
(GDF), and extracellular matrix proteins like enamel matrix
proteins (EMD) or use of a combination of the above tech-
n i q u e sa n dm a t e r i a l sw h i c hh a sb e e ne x t e n s i v e l yr e v i e w e d
elsewhere [69].
A sulcular incision ﬂap or papilla preservation ﬂap will
be the ideal technique to minimize recession in the anterior
regions due to esthetic reasons, and modiﬁed Widman ﬂap
orconventional/sulcularincisionﬂapwillbethetechniqueof
choiceintheposterior regions whenopting forbonegrafting
and another regenerative therapy. A papilla preservation ﬂap
is preferred for bone grafting when there is spacing between
the teeth to obtain maximum coverage of the graft material
at the interdental region and to prevent shrinkage of papillaCase Reports in Medicine 11
on healing [67]. Biomodiﬁcation of the root surface (Root
conditioning) with citric acid, tetracycline, or ﬁbronectin is
preferable when performing bone grafting or GTR for better
clinical results [69].
7.2.2. Bone Replacement Grafts. Bone grafting is indicated in
vertical defects, and the success of the procedure depends
on the type of defect. Three-walled or intrabony defect is
the ideal defect for bone grafts and has a better success
rate compared to a two-walled and one-walled defect. The
type of bone graft which gives the maximum beneﬁt with
minimum tissue reaction is autograft [70], but there are
limitations of obtaining it in large quantities as is needed
in most cases of generalized aggressive periodontitis. A more
feasible option is to use commercially available bone grafts,
which are allograft, xenograft, or alloplastic materials.
Allograftsusedforperiodontalgraftsincludemineralized
freeze-dried bone allografts (FDBAs) which are osteocon-
ductive, and decalciﬁed freeze-dried bone allografts (DFD-
BAs) which are osteoinductive. Decalciﬁcation of the graft
exposes the complex bone morphogenic proteins (BMPs)
from its matrix which can induce osteoblastic proliferation
in the recipient site. DFDBA, because of its osteoinductive
property, has shown to have better results than the alloplastic
materials which are osteoconductive [71]. Allogeneic freeze-
dried bone (FDBA) mixed with tetracycline powder along
with systemic tetracycline has demonstrated a better clinical
outcome in treatment of juvenile periodontitis [72].
Xenografts used are either bovine derived or coral
derived.Anosteoconductivebovine-derivedanorganicbone,
Bio-Oss, has been successfully used in periodontal defects
with resulting bone regeneration and new attachment in
these defects [73–75]. Human histologic studies have shown
that a combination of Bio-Oss with either puriﬁed porcine
collagen (Bio-Oss Collagen) [76] or a synthetic cell-binding
polypeptide (Pepgen P-15) [77] has the capacity of inducing
regeneration of the periodontal attachment apparatus when
placed in intrabony defects. Coralline grafts implanted into
human periodontal defects have produced better clinical
results when compared to nongrafted sites [78].
Synthetic grafts/alloplastic grafts have been considered
primarily as defect ﬁllers. The most commonly used among
alloplastic graft materials is hydroxyapatite (HAP) which is
osteoconductive and has shown to have similar clinical eﬀect
to FDBA [79]. Other alloplastic grafts which can be used are
beta tricalcium phosphate and bioactive glass [80, 81].
A synthetic hydroxyapatite/equine type I collagen/chon-
droitin sulphate biomaterial (Biostite) has been found to
show comparable improvements to Bio-Oss in terms of
clinical attachment gain, pocket depth reduction, and radio-
graphicboneﬁllinthetreatmentofdeepintraosseousdefects
[82].
7.2.3. Guided Tissue Regeneration. Guided tissue regenera-
tion promotes regeneration by acting as a barrier which
prevents apical migration of epithelium and exclude gingival
connective tissue from the healing wound, thus allowing the
pluripotent periodontal ligament cells to populate the site
of healing enhancing new cementum and new attachment
procedures.
GTR has shown to have a greater eﬀect on probing mea-
sures of periodontal treatment than open ﬂap debridement
alone, including improved attachment gain, reduced pocket
depth, less increase in gingival recession, and more gain in
hard tissue probing at reentry surgery [83]. Research has
shownthatGTRinconjunctionwithbonegraftinghasbetter
potential for regeneration compared with either technique
alone [74, 84, 85], and this outcome has been conﬁrmed in
aggressive periodontitis also with the use of bioresorbable
membranes (Bio-Gide) [75, 80].
7.2.4. Biologic Mediators and Extracellular Proteins. Aw i d e
array of regenerative materials is being considered for use in
periodontitis. Use of biologic mediators like growth factors
(insulin-like growth factor (ILGF), platelet-derived growth
factor (PDGF)) use of platelet-rich plasma which contains
PDGF, extracellular matrix proteins like emdogain, etc. are
of promising results. Application of enamel matrix proteins
alone [86] or in combination with bone grafts including
bioactiveglasshasshowntoresultinthesuccessfultreatment
of intrabony defects in aggressive periodontitis [87].
Beneﬁcial eﬀects of platelet-rich plasma (PRP) in the
treatment of periodontal defects have been demonstrated
by clinical and radiographic measurements together with
reentry results showing marked improvements from baseline
with increased stabilization of whole dentition including the
hopeless teeth [88, 89].
Various commercially available regenerative materials
includingbonereplacementgrafts,GTRmembranes,enamel
matrix derivatives, are in the market for use in periodontal
therapy with varying results, and the choice of the material
depends on the dentist’s preference and experience with the
products helping in clinical judgment of the therapeutic
results of individual products and procedures and their cost-
beneﬁt ratio.
7.3.RoleofMaintenanceTherapyinManagementofAggressive
Periodontitis. The importance of supportive periodontal
therapy has to be stressed in management of aggressive per-
iodontitis. Regular SPT was found to be eﬀective in main-
taining clinical and microbiological improvements attained
after active periodontal therapy in early onset periodontitis
[90].
The maintenance therapy starts soon after the phase I
therapy or nonsurgical therapy and should be continued
throughout the lifetime of the patient. Or in other words,
“maintenance therapy never ends”f o raG A g Pp a t i e n t .I n
order to maintain the optimal results got by surgery and to
prevent the recurrence of the disease, a lifelong maintenance
therapy is mandatory because of the strong genetic suscepti-
bility of the individual to the disease.
Thefrequencyoftherecallvisitsdependsontheresponse
of the individual to treatment and presence of other risk
factors like environmental factors but generally will be more
frequent than that in chronic periodontitis or in localized
aggressive periodontitis. Any site which shows signs of12 Case Reports in Medicine
recurrence of the disease like bleeding on probing which is
consideredastheﬁrstclinicalsignofinﬂammationshouldbe
treated vigorously and monitored for resolution of the signs.
7.4. Interdisciplinary Approach for Management of Resultant
Esthetic, Functional, and Psychologic Problems in GAgP. A
comprehensive management for total rehabilitation of the
GAgP patients not only involves control of infection and ar-
rest of progression and/or regenerative therapy by the peri-
odontist but also incorporates a multidisciplinary approach
to attend the esthetic, functional, and psychologic problems
faced by the patient.
An orthodontic therapy with concomitant periodontal
monitoring and prosthetic rehabilitation, if possible with the
use of implants and psychologic counseling, may be needed
for patients with advanced forms of the disease.
7.4.1. Combined Periodontal-Orthodontic Therapy. Cosmetic
concerns in young aggressive periodontitis patients will be
high since the disease can result in ﬂaring, protrusion,
pathologic migration, and even extrusion of the anterior
teeth. Malocclusion, pathologic migration and potential
occlusaltraumatismwhichcancausesecondarytraumafrom
occlusion can be corrected by orthodontic therapy in GAgP
patients already stabilized by periodontal therapy [91–94].
Orthodontic treatment can be commenced once attachment
gain and bone stability is achieved after periodontal therapy
but is generally advised to postpone till 3 months to 1 year
afteractiveperiodontaltherapy.Acombinedperiodontaland
orthodontictreatmentdemandsadetailedevaluationinboth
specialties, particularly when the periodontium is reduced.
Periodontal evaluations are scheduled concomitantly with
orthodontic appointments to monitor the periodontal sta-
bility as the tooth movement occurs.
7.4.2. Prosthodontic Rehabilitation, Implant Therapy, and
Implant Supported Prosthesis. Gingival recession with loss
of interdental papilla especially in the anterior teeth is un-
aestheticespeciallywhenthepatientsmilesandthefeasibility
of root coverage periodontal plastic surgery will be limited
in generalized aggressive periodontitis because of the large
number of teeth involved and the advanced interdental
bone loss. A porcelain, resin, silicone, or copolyamide re-
movable gingival prosthesis (gum veneer/gingival mask)
can be fabricated to mask the recession and improve the
appearance of the anterior teeth [95]. The restoration of the
teeth lost due to periodontitis should be done with ﬁxed or
removable prosthesis depending on the bone support of the
remaining teeth.
Contradictory to the earlier concept that implants are
not a feasible option in GAgP patients, the use of implants
and implant-supported prosthesis to restore the lost teeth
is increasingly considered as a treatment option in well-
maintained GAgP patients even though the risk of bone
loss and attachment loss around implants is higher than
that in chronic periodontitis patients or periodontally
healthy individuals, with researches showing good survival
of implants over a 10-year period [96]. Several reports are
there which have successfully used osseointegrated implants
in oral rehabilitation of partially edentulous patients treated
for GAgP [97–99].
7.4.3. Psychotherapy. Perhaps the least recognized and the
most underestimated aspect in the total rehabilitation
of a patient with GAgP presenting with multiple tooth
loss and/or advanced periodontal destruction necessitating
extraction of multiple teeth is the need for psychological
counseling and psychotherapy. It aims at attending the
psychologic eﬀect and potential mental depression following
tooth loss due to rapid periodontal destruction which
provides the patient with relatively less time to cope with the
situation. The emotional eﬀects of tooth loss are devastating
for some patients and have a dramatic impact on their life,
and they take longer time to come to terms with the tooth
loss [100]. Preparing the patients with advanced disease
having multiple teeth with hopeless prognosis emotionally
for extraction also has to be dealt with carefully by the
dentist, if needed using multiple appointments, and the
extent of the impact that bad news, such as having to lose
teeth, has on an individual is most often dependent on the
way in which the information is communicated [101]. De-
pression, anxiety and social withdrawal are seen in patients
with tooth loss, and resulting compromised esthetics can
be helped with therapy, relaxation techniques, and, in some
cases, antidepressants. Any of the above symptoms should
be addressed with a qualiﬁed psychotherapist to improve the
quality of life.
Psychotherapy has to be started immediately following
the ﬁrst appointment and should be continued concomi-
tantly for total rehabilitation of the patient for a variable
duration depending upon the psychologic status of the
individual patient. In addition, stress reduction protocols
may help in management of the disease as such in the view
of the recent suggestions of the proposed mechanisms by
which stress can contribute to the onset, exacerbation and
maintenance of the periodontal disease [102] .Ar e c e n ts t u d y
reported that psychotherapy oﬀered at 3 levels (individual,
group, and conjoint family psychotherapy) to GAgP patients
gave positive psychologic eﬀects that restored their ability
to socialize in their environment contributing to their
positive experience in life [103]. The above facts suggest that
psychotherapy be incorporated for the future protocols for
treatment of GAgP patients suﬀering from emotional eﬀects
of tooth loss.
7.4.4. Other Treatment Modalities and Future Trends in Man-
agement of Aggressive Periodontitis. Host modulation ther-
apy with systemically and locally administered agents is
under research for therapy in aggressive periodontitis.
Subantibacterial dose of Doxycycline has been approved
for use in chronic periodontitis, but its use in aggressive
periodontitis has to be conﬁrmed by research. Adjunctive
use of locally administered alendronate gel with SRP for
host modulation has shown promising results in aggressive









































































































































































































































































































































































































Figure 14: The treatment commences with a nonsurgical phase following which psychotherapy sessions are started for the needy patients,
and patients are put on maintenance therapy/supportive periodontal therapy thereafter. While the patient is on maintenance therapy, one or
more of the 3 modalities of surgical periodontal therapy can be performed depending upon the indication and once periodontium has been
stabilized, an interdisciplinary treatment for the restoration of lost teeth and correction of cosmetic problems is completed following which
the patient continues for a “lifelong” maintenance therapy.
Newer generations of regenerative materials and ad-
vances in tissue engineering for regeneration and genetic
engineering to modify the genetic risk factors seem to be
really promising in the future. With further understanding
of the genetic risk factors, a futuristic application of genetic
screening tests will be in identifying the susceptible individ-
uals and instituting the preventive measures to keep the gene
expression and thus the disease under control [105, 106].
7.4.5. A Suggested Protocol for the Comprehensive and Total
Rehabilitation of GAgP Patients with the Current Treatment
Modalities. For more details see Figure 14.
8. Conclusion
Even though the prevalence of aggressive periodontitis is
much lower than chronic periodontitis, the management of
aggressive periodontitis is more challenging compared to
that of chronic periodontitis because of its strong genetic
predispositionasanunmodiﬁableriskfactor.Researchersare
going on employing the potential several novel technologies
in regenerating the lost periodontium including tissue
engineering and genetic engineering.
The key to successful management at present lies in early
diagnosis of the disease and rigorous treatment employ-
ing the diﬀerent treatment modalities mentioned in the
paper along with systemic antibiotic therapy followed by
meticulous lifelong maintenance therapy. With the current
treatment modalities, successful long-term maintenance of
the dentition in a healthy and functional state can be
achieved. A comprehensive periodontal treatment consisting
of mechanical/surgical and systemic antimicrobial therapy is
found to be an appropriate treatment regimen for long-term
stabilization of periodontal health with arrest of periodontal
disease progression in 95% of the initially compromised
lesions [107].
Further understanding of the etiology, risk factors, path-
ogenesis, and host immune response in aggressive periodon-
titis along with advances in regenerative concepts, tissue en-
gineering, and gene therapy is needed for formulating bet-
ter management protocols in the treatment of generalized
aggressive periodontitis.
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